logologo
QuantliQuantli

Krystal Biotech Inc

KRYS

NASDAQ

Biotechnology

$332.27

USD

+3.93 (+1.20%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $9.71B

Volume 167.9K

Price Target

$361.00$403.00

USD

The 2 analysts offering 1-year price forecasts have a max estimate of $403.00 and a min estimate of $361.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$382.00

+$63.0 vs prior

Implied Upside

+15.0%

+19.0% vs prior

Analyst Covering

2

-3 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

29%

Many ratings are older - consensus may be less current

Analyst Agreement

High

Targets are closely clustered - analysts agree more than usual

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

2 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

2 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Ritu Baral

TD Cowen

Buy

Maintained

1 month ago

Plus
Plus
Plus

Joseph Pantginis

HC Wainwright & Co.

Buy

Maintained

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

IONS

Ionis Pharmaceuticals Inc

$57.24

+2.5%

APGE

Apogee Therapeutics Inc

$134.55

+0.1%

PRAX

Praxis Precision Medicines Inc

$366.81

-0.5%

PTGX

Protagonist Therapeutics Inc

$155.10

+2.4%

CYTK

Cytokinetics Inc

$74.13

+0.9%

KYMR

Kymera Therapeutics Inc

$117.39

+2.6%

PCVX

Vaxcyte Inc

$58.07

-1.3%

IMVT

Immunovant Inc

$41.82

0.0%

SYRE

Spyre Therapeutics Inc

$103.63

+1.8%